R&D to Revenue
22.12%
Quarterly · Period ending:
LUNG R&D to Revenue
Latest reported22.12%period ending
Latest reported22.12%period ending
LUNG Quarterly R&D/Revenue (23.18% → 22.12%)
Latest values, visible window
High-resolution chart · PNG
LUNG r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 22.1216% | |
| 23.7977% | |
| 20.2806% | |
| 22.5374% | |
| 22.239% | |
| 21.1021% | |
| 16.8357% | |
| 18.3646% | |
| 27.0173% | |
| 22.3295% | |
| 20.2096% | |
| 23.885% | |
| 33.2093% | |
| 29.2604% | |
| 25.3031% | |
| 32.336% | |
| 25.7634% | |
| 32.7677% | |
| 27.0499% | |
| 21.2277% | |
| 28.7306% | |
| 32.8213% | |
| 25.1475% | |
| 18.8183% | |
| 38.8238% | |
| 18.1597% | |
| 15.4924% | |
| 15.3669% | |
| 19.7122% | |
| 23.1817% |